Huang Yunyu, Jiang Youfen, Zhang Luying, Mao Wenhui, van Boven Job F M, Postma Maarten J, Chen Wen
School of Public Health, Fudan University, 130 Dong'an Road, Shanghai, 200032, China.
Unit of PharmacoTherapy, Epidemiology & Economics, Department of Pharmacy, University of Groningen, Antonius Deusinglaan 1, 9713, AV, Groningen, The Netherlands.
BMC Health Serv Res. 2018 Mar 27;18(1):218. doi: 10.1186/s12913-018-2993-1.
This study aimed to examine the availability, use, and affordability of medicines in urban China following the 2009 Health Care System Reform that included implementation of universal health coverage (UHC).
This longitudinal study was performed in Hangzhou (high income, eastern China) and Baoji (lower income, western China). Five yearly household surveys were conducted (one each year from 2009 to 2013) to evaluate the impact of UHC on medicines use and expenditure, and a health facility survey was conducted in 2013 to evaluate availability of medicines. A cohort of over 800 households in Hangzhou and Baoji was established in 2009, and 20 hospitals were included in the health facility survey. Medicines use was determined using data from health facility and household surveys. An average, two-week out-of-pocket medicines expenditure was calculated to assess the affordability of medicines.
The number of medicines stocked in primary health facilities in Hangzhou decreased, while the number in Baoji increased. In Baoji, patients usually chose a pharmacy to buy medicines directly, despite the 48.2% increased availability of essential medicines in primary health care centers. The majority of survey respondents stated that their medicines need was basically met; however, medicines cost still accounted for a major part of their health expenditure. Medicines expenditure showed an increasing trend from 2009 to 2013. The average annual growth rate of household overall medical expenditure was significantly higher than that for household non-food consumption expenditure.
Following China's Health Care System Reform and implementation of UHC, availability and use of medicines has improved in urban areas. However, the affordability of medicines is still a concern.
本研究旨在考察2009年医疗体系改革(包括实施全民医保)后中国城市地区药品的可及性、使用情况和可负担性。
本纵向研究在杭州(中国东部高收入地区)和宝鸡(中国西部低收入地区)开展。进行了五次年度家庭调查(2009年至2013年每年一次)以评估全民医保对药品使用和支出的影响,并于2013年进行了一次医疗机构调查以评估药品的可及性。2009年在杭州和宝鸡建立了一个超过800户家庭的队列,医疗机构调查纳入了20家医院。药品使用情况通过医疗机构和家庭调查数据确定。计算了平均两周的自付药品支出以评估药品的可负担性。
杭州基层医疗卫生机构的药品储备数量减少,而宝鸡的药品储备数量增加。在宝鸡,尽管基层医疗卫生机构基本药物的可及性提高了48.2%,但患者通常仍选择直接去药店买药。大多数调查受访者表示他们的用药需求基本得到满足;然而,药品费用仍占其医疗支出的很大一部分。2009年至2013年药品支出呈上升趋势。家庭总体医疗支出的年均增长率显著高于家庭非食品消费支出的年均增长率。
在中国医疗体系改革及全民医保实施后,城市地区药品的可及性和使用情况有所改善。然而,药品的可负担性仍是一个问题。